Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy
- ACS Med Chem Lett. 2022 Mar 4;13(4):528-529. doi: 10.1021/acsmedchemlett.2c00085.
Affiliations
- 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 35450363
DOI: 10.1021/acsmedchemlett.2c00085
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Kallikrein